Chromosomal imbalances in primary oligodendroglial tumors and their recurrences: Clues about malignant progression detected using comparative genomic hybridization

Journal of Neurosurgery

Volumn 96, Issue 3, 2002, Pages 559-564

  Jeuken, Judith W M ^a   Sprenger, Sandra H E ^a   Vermeer, Harry ^a   Kappelle, Arnoud C ^a   Boerman, Rudolf H ^a   Wesseling, Pieter ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Comparative genomic hybridization; Histological study; Oligoastrocytoma; Oligodendroglioma; Progressive disease; Tumor recurrence

Indexed keywords

ADULT; ARTICLE; ASTROCYTOMA; CANCER GROWTH; CELL CYCLE; CELL PROLIFERATION; CHROMOSOME 10; CHROMOSOME 19Q; CHROMOSOME 1P; CHROMOSOME 7; CHROMOSOME ABERRATION; CHROMOSOME LOSS; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GENETIC PREDISPOSITION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; OLIGODENDROGLIOMA; PRIORITY JOURNAL; TUMOR GROWTH; TUMOR RECURRENCE;

EID: 0036119688     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/jns.2002.96.3.0559     Document Type: Article

References (27)

1. Specific chromosomal abnormalities characterize four established cell lines derived from malignant human gliomas
2. Molecular genetic aspects of oligodendrogliomas including analysis by comparative genomic hybridization
3. Morphologic and molecular genetic aspect of oligodendroglial neoplasms
4. Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas
5. Astrocytic tumors
6. Genetic alterations in gliomas
7. Genetics and malignant progression of human brain tumours
8. CDK4 amplification is an alternative mechanism to p16 gene homozygeous deletion in glioma cell lines
9. 1KN4 or retinoblastoma protein (pRb), or amplification-associated overexpression of cdk4 is observed in distinct subsets of malignant glial tumors and cell lines
10. Subtyping of oligo-astrocytic tumours by comparative genomic hybridization
11. Identification of subgroups of high-grade oligodendroglial tumors by comparative genomic hybridization
12. Primary and secondary glioblastomas: From concept to clinical diagnosis
13. Histopathology, classification, and grading of gliomas
14. Genetic aberrations in oligodendroglial tumours: An analysis using comparative genomic hybridization (CGH)
15. Genetic aberrations in human brain tumors
16. A molecular genetic model of astrocytoma histopathology
17. Clinical evidence of distinct subgroups of astrocytic tumors defined by comparative genomic hybridization
18. Genetic alterations associated with the evolution and progression of astrocytic brain tumours
19. Oligodendroglial tumours and mixed gliomas
20. Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p
21. Detection of complex genetic alterations in human glioblastoma multiforme using comparative genomic hybridization
22. CDKN2(p16/ MTS1) gene deletion or CDK 4 amplification occurs in the majority of glioblastomas
23. Recurrent gain of chromosome arm 7q in low-grade astrocytic tumors studied by comparative genomic hybridization
24. Molecular changes during the genesis of human gliomas
25. Molecular genetic analysis of non-astrocytic gliomas
26. CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated
27. Characterization of genomic alterations associated with glioma progression by comparative genomic hybridization